Related Experiment Video

Updated: Dec 30, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

9.3K

[Clinical advances in targeted therapy and immunotherapy for hepatocellular carcinoma]

D Z Zhang1, J Q Niu

  • 1The First Hospital of Jilin University, Changchun 130021, China.

Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|January 17, 2020
PubMed

Insights

Hepatocellular carcinoma (HCC) is a major health concern in China. Recent advances in systemic drug therapy, including molecular targeted drugs and immune checkpoint blockers, show promise for advanced HCC but face challenges.

Area of Science:

  • Hepatology
  • Oncology
  • Pharmacology

Background:

  • Hepatocellular carcinoma (HCC) presents a significant public health challenge in China, marked by high incidence and mortality rates.
  • HCC is a leading cause of cancer-related death across all Chinese provinces.
  • The management of HCC requires continuous innovation in therapeutic strategies.

Purpose of the Study:

  • To review the recent advancements in systemic drug therapy for advanced hepatocellular carcinoma (HCC).
  • To highlight the progress and limitations of molecular targeted drugs and immune checkpoint blockers in HCC treatment.
  • To provide an overview of the current landscape of drug therapy for advanced HCC.

Main Methods:

  • Literature review of recent studies on systemic drug therapy for advanced HCC.
  • Analysis of clinical trial data and research publications on molecular targeted drugs and immune checkpoint inhibitors.
  • Synthesis of information on the efficacy and challenges of current drug treatments for HCC.

Main Results:

  • Systemic drug therapy for HCC has seen rapid development, with molecular targeted drugs and immune checkpoint blockers emerging as key treatments.
  • These therapies have demonstrated progress in managing advanced HCC.
  • Despite advancements, significant challenges and unmet needs persist in the drug treatment of advanced HCC.

Conclusions:

  • Molecular targeted drugs and immune checkpoint blockers represent significant progress in advanced HCC treatment.
  • Further research and development are crucial to overcome existing challenges and improve patient outcomes.
  • The landscape of HCC drug therapy is evolving, offering new hope for patients with advanced disease.
Keywords:
Carcinoma, hepatocellularImmunotherapyTargeted therapy

More Related Videos

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

1.7K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.9K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
884
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K